Stocks
Jazz Pharmaceuticals plcJAZZ
NASDAQHealthcareBiotechnology$178.55-0.98%
A specialty biopharmaceutical company focused on treatments for sleep disorders, epilepsy, and oncology, with key products including therapies for narcolepsy and rare neurological conditions. The Ireland‑domiciled firm expanded its portfolio through acquisitions such as GW Pharmaceuticals, adding th...
Market Cap: $11.0B52W Range: $95.49 – $198.00
Congressional Interest in Jazz Pharmaceuticals plc (JAZZ)
5 members of Congress have disclosed 8 trades in Jazz Pharmaceuticals plc (JAZZ), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 5 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
8
Unique Politicians
5
Buys
3
Sells
5
Who in Congress Is Trading JAZZ?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-07-12 | Daniel Goldman | sell | $15K – $50K |
| 2023-03-14 | Rohit Khanna | sell | $1K – $15K |